ESSILORLUXOTTICA (EL.PA) Stock Fundamental Analysis

EPA:EL • FR0000121667

214.95 EUR
-4.35 (-1.98%)
Last: Mar 3, 2026, 05:12 PM
Fundamental Rating

5

Overall EL gets a fundamental rating of 5 out of 10. We evaluated EL against 63 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of EL get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, EL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • EL had positive earnings in the past year.
  • EL had a positive operating cash flow in the past year.
  • In the past 5 years EL has always been profitable.
  • Each year in the past 5 years EL had a positive operating cash flow.
EL.PA Yearly Net Income VS EBIT VS OCF VS FCFEL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.62%, EL is in line with its industry, outperforming 53.97% of the companies in the same industry.
  • EL has a Return On Equity of 5.95%. This is comparable to the rest of the industry: EL outperforms 46.03% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.96%, EL is in line with its industry, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
ROA 3.62%
ROE 5.95%
ROIC 4.96%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EL.PA Yearly ROA, ROE, ROICEL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • EL has a Profit Margin of 8.13%. This is in the better half of the industry: EL outperforms 60.32% of its industry peers.
  • EL's Profit Margin has improved in the last couple of years.
  • EL has a Operating Margin (11.85%) which is comparable to the rest of the industry.
  • EL's Operating Margin has improved in the last couple of years.
  • EL has a Gross Margin of 59.69%. This is comparable to the rest of the industry: EL outperforms 58.73% of its industry peers.
  • EL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.85%
PM (TTM) 8.13%
GM 59.69%
OM growth 3Y-2.08%
OM growth 5Y30.97%
PM growth 3Y-2.57%
PM growth 5Y69.02%
GM growth 3Y-1.64%
GM growth 5Y0.64%
EL.PA Yearly Profit, Operating, Gross MarginsEL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EL is destroying value.
  • EL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EL.PA Yearly Shares OutstandingEL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
EL.PA Yearly Total Debt VS Total AssetsEL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 3.11 indicates that EL is not in any danger for bankruptcy at the moment.
  • EL has a Altman-Z score of 3.11. This is in the better half of the industry: EL outperforms 60.32% of its industry peers.
  • The Debt to FCF ratio of EL is 3.82, which is a good value as it means it would take EL, 3.82 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 3.82, EL is doing good in the industry, outperforming 63.49% of the companies in the same industry.
  • EL has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.24, EL is in the better half of the industry, outperforming 65.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.82
Altman-Z 3.11
ROIC/WACC0.63
WACC7.9%
EL.PA Yearly LT Debt VS Equity VS FCFEL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 0.99 indicates that EL may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.99, EL is doing worse than 80.95% of the companies in the same industry.
  • A Quick Ratio of 0.70 indicates that EL may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.70, EL is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.7
EL.PA Yearly Current Assets VS Current LiabilitesEL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

6

3. Growth

3.1 Past

  • EL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.90%.
  • EL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.65% yearly.
  • The Revenue has been growing slightly by 7.48% in the past year.
  • The Revenue has been growing by 14.58% on average over the past years. This is quite good.
EPS 1Y (TTM)0.9%
EPS 3Y2.19%
EPS 5Y30.65%
EPS Q2Q%-0.64%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y5.17%
Revenue growth 5Y14.58%
Sales Q2Q%9.45%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.89% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 8.09% on average over the next years. This is quite good.
EPS Next Y17.32%
EPS Next 2Y16.06%
EPS Next 3Y13.67%
EPS Next 5Y13.89%
Revenue Next Year11.54%
Revenue Next 2Y11.17%
Revenue Next 3Y10.73%
Revenue Next 5Y8.09%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EL.PA Yearly Revenue VS EstimatesEL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
EL.PA Yearly EPS VS EstimatesEL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

  • EL is valuated quite expensively with a Price/Earnings ratio of 31.38.
  • EL's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.13, EL is valued at the same level.
  • With a Price/Forward Earnings ratio of 26.74, EL can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EL indicates a slightly more expensive valuation: EL is more expensive than 60.32% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.11. EL is around the same levels.
Industry RankSector Rank
PE 31.38
Fwd PE 26.74
EL.PA Price Earnings VS Forward Price EarningsEL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • EL's Enterprise Value to EBITDA is on the same level as the industry average.
  • EL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EL is cheaper than 63.49% of the companies in the same industry.
Industry RankSector Rank
P/FCF 26.44
EV/EBITDA 17.33
EL.PA Per share dataEL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EL does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as EL's earnings are expected to grow with 13.67% in the coming years.
PEG (NY)1.81
PEG (5Y)1.02
EPS Next 2Y16.06%
EPS Next 3Y13.67%

6

5. Dividend

5.1 Amount

  • EL has a Yearly Dividend Yield of 1.67%.
  • The stock price of EL dropped by -27.53% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 1.06, EL pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, EL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.67%

5.2 History

  • The dividend of EL has a limited annual growth rate of 4.50%.
Dividend Growth(5Y)4.5%
Div Incr Years3
Div Non Decr Years4
EL.PA Yearly Dividends per shareEL.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • EL pays out 23.63% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of EL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP23.63%
EPS Next 2Y16.06%
EPS Next 3Y13.67%
EL.PA Yearly Income VS Free CF VS DividendEL.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
EL.PA Dividend Payout.EL.PA Dividend Payout, showing the Payout Ratio.EL.PA Dividend Payout.PayoutRetained Earnings

ESSILORLUXOTTICA

EPA:EL (3/3/2026, 5:12:16 PM)

214.95

-4.35 (-1.98%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)04-22
Inst Owners28.97%
Inst Owner ChangeN/A
Ins Owners32.07%
Ins Owner ChangeN/A
Market Cap99.58B
Revenue(TTM)28.49B
Net Income(TTM)2.31B
Analysts85.16
Price Target331.09 (54.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.67%
Yearly Dividend2.56
Dividend Growth(5Y)4.5%
DP23.63%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.07%
PT rev (3m)2.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)3.75%
Revenue NY rev (3m)5.04%
Valuation
Industry RankSector Rank
PE 31.38
Fwd PE 26.74
P/S 3.5
P/FCF 26.44
P/OCF 18.82
P/B 2.56
P/tB N/A
EV/EBITDA 17.33
EPS(TTM)6.85
EY3.19%
EPS(NY)8.04
Fwd EY3.74%
FCF(TTM)8.13
FCFY3.78%
OCF(TTM)11.42
OCFY5.31%
SpS61.5
BVpS83.94
TBVpS-4.05
PEG (NY)1.81
PEG (5Y)1.02
Graham Number113.74
Profitability
Industry RankSector Rank
ROA 3.62%
ROE 5.95%
ROCE 6.52%
ROIC 4.96%
ROICexc 5.33%
ROICexgc 34.55%
OM 11.85%
PM (TTM) 8.13%
GM 59.69%
FCFM 13.22%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.08%
OM growth 5Y30.97%
PM growth 3Y-2.57%
PM growth 5Y69.02%
GM growth 3Y-1.64%
GM growth 5Y0.64%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 3.82
Debt/EBITDA 1.46
Cap/Depr 48.99%
Cap/Sales 5.35%
Interest Coverage 250
Cash Conversion 81.55%
Profit Quality 162.68%
Current Ratio 0.99
Quick Ratio 0.7
Altman-Z 3.11
F-Score7
WACC7.9%
ROIC/WACC0.63
Cap/Depr(3y)49.88%
Cap/Depr(5y)48.88%
Cap/Sales(3y)5.71%
Cap/Sales(5y)5.75%
Profit Quality(3y)150.08%
Profit Quality(5y)168.44%
High Growth Momentum
Growth
EPS 1Y (TTM)0.9%
EPS 3Y2.19%
EPS 5Y30.65%
EPS Q2Q%-0.64%
EPS Next Y17.32%
EPS Next 2Y16.06%
EPS Next 3Y13.67%
EPS Next 5Y13.89%
Revenue 1Y (TTM)7.48%
Revenue growth 3Y5.17%
Revenue growth 5Y14.58%
Sales Q2Q%9.45%
Revenue Next Year11.54%
Revenue Next 2Y11.17%
Revenue Next 3Y10.73%
Revenue Next 5Y8.09%
EBIT growth 1Y-2.12%
EBIT growth 3Y2.98%
EBIT growth 5Y50.07%
EBIT Next Year73.26%
EBIT Next 3Y27.8%
EBIT Next 5Y18.52%
FCF growth 1Y12.35%
FCF growth 3Y5.46%
FCF growth 5Y10.35%
OCF growth 1Y8.56%
OCF growth 3Y3.42%
OCF growth 5Y12.38%

ESSILORLUXOTTICA / EL.PA FAQ

What is the ChartMill fundamental rating of ESSILORLUXOTTICA (EL.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to EL.PA.


What is the valuation status for EL stock?

ChartMill assigns a valuation rating of 3 / 10 to ESSILORLUXOTTICA (EL.PA). This can be considered as Overvalued.


What is the profitability of EL stock?

ESSILORLUXOTTICA (EL.PA) has a profitability rating of 6 / 10.


What is the valuation of ESSILORLUXOTTICA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ESSILORLUXOTTICA (EL.PA) is 31.38 and the Price/Book (PB) ratio is 2.56.


Can you provide the dividend sustainability for EL stock?

The dividend rating of ESSILORLUXOTTICA (EL.PA) is 6 / 10 and the dividend payout ratio is 23.63%.